HEMGENIX Overview

  • Status
  • Private

HEMGENIX General Information

Description

Developer of a one-time infusion that delivers long-lasting protection against bleeding episodes. The company offers a gene therapy that reduces the rate of abnormal bleeding in eligible people with hemophilia B by enabling the body to continuously produce factor IX, the deficient protein in hemophilia B.

Contact Information

Website
www.hemgenix.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 1020 First Avenue
  • King of Prussia, PA 19406
  • United States
Primary Industry
Other Healthcare Services
Corporate Office
  • 1020 First Avenue
  • King of Prussia, PA 19406
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ready to get started?

Request a free trial

HEMGENIX FAQs

  • Where is HEMGENIX headquartered?

    HEMGENIX is headquartered in King of Prussia, PA.

  • What industry is HEMGENIX in?

    HEMGENIX’s primary industry is Other Healthcare Services.

  • Is HEMGENIX a private or public company?

    HEMGENIX is a Private company.

  • What is HEMGENIX’s current revenue?

    The current revenue for HEMGENIX is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process